University Hospital, Lille — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University Hospital, Lille appears in 167 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials167

Recruiting shown28

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Predictive Value of the Optic Nerve Involvement in Clinically Isolated SyndromeNCT06455332 · lead sponsor · 2025-07-17

Anxiety in Patients Under Active Surveillance for Localized Prostate Cancer and Their Partners.NCT07351461 · lead sponsor · 2025-03-23

Social & Affective Cognition in Alzheimer's Disease & Associated DisordersNCT06338397 · lead sponsor · 2025-01-28

EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.NCT06448572 · lead sponsor · 2024-07-16

Incidence of Major Complication in Case of Thoracic Aortic AneurysmNCT05395598 · lead sponsor · 2024-04-18

Clinical and Objective Psychiatric Analyses in Severe Depression.NCT06095310 · lead sponsor · 2023-11-30

Impact of Long-acting Bronchodilator- -Corticoid Inhaled Therapy on Ventilation, Lung Function and BreathlessnessNCT06110403 · lead sponsor · 2023-09-29

Food Frequency Questionnaire to Assess Sodium IntakeNCT05533645 · lead sponsor · 2023-06-06

Evaluation of Cortisol and Bile Acids Metabolism in Obese PatientsNCT04844684 · lead sponsor · 2023-03-30

Tanycytes in Alzheimer's Disease and Frontotemporal DementiaNCT05288842 · lead sponsor · 2022-09-06

fMRI-based Neurofeedback to Relieve Drug-resistant Auditory HallucinationsNCT04798131 · lead sponsor · 2022-08-26

The IMmunotherapy Pleural 5-ALA PDTNCT04400539 · lead sponsor · 2022-05-09

Metabolism, Circadian Rhythms and Ovarian FunctionNCT05007834 · lead sponsor · 2022-02-24

Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.NCT04573673 · lead sponsor · 2021-12-01

Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical VentilationNCT04530760 · lead sponsor · 2021-10-08

Evaluation of Long-term Adverse Effects of Gastric Bypass in OmegaNCT04930029 · lead sponsor · 2021-09-15

Prediction of Heart Failure and Cognitive Decline in Type 2 DiabetesNCT04583800 · lead sponsor · 2021-06-22

Effect of CAFfeine on Cognition in Alzheimer's DiseaseNCT04570085 · lead sponsor · 2021-03-01

Early Gestational Diabetes MellitusNCT04451915 · lead sponsor · 2020-11-30

Evaluation of a New Communication Aid Tool to Favor Global Patient Centered CareNCT04179695 · lead sponsor · 2020-07-21

Deployment o the Multidisciplinary Prospective Cohort ImminentNCT04334031 · lead sponsor · 2020-07-20

Exercise Training and Endothelial Function in Type 1 DiabetesNCT03528226 · lead sponsor · 2019-11-12

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV).NCT03713203 · lead sponsor · 2019-08-27

Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.NCT03821636 · lead sponsor · 2019-06-16

A Clinico-biological Database of Lung CancersNCT03387865 · lead sponsor · 2019-03-13

Determinants of the Long-Term Success of Bariatric SurgeryNCT03517072 · lead sponsor · 2018-07-31

A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese PatientsNCT03472157 · lead sponsor · 2018-06-20

A Biological Atlas of Severe Obesity (Biological Tissue Collection)NCT01129297 · lead sponsor · 2006-06-13

Lung Disease and FLNA MutationsNCT07592637 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

Prevention of Renal Failure in People Followed for Type 2 Diabetes in General PracticeNCT05749679 · lead sponsor · 2026-07-01

NOT_YET_RECRUITING

Switch to Ofatumumab and Level of ImmunoglobulinsNCT07625800 · lead sponsor · 2026-06-01

NOT_YET_RECRUITING

Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.NCT07475325 · lead sponsor · 2026-04-20

ACTIVE_NOT_RECRUITING

Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis CancersNCT06958224 · lead sponsor · 2026-04-10

NOT_YET_RECRUITING

Evaluation of Long-term Safety in Parkinsonian Patients With Intracerebroventricular Administration of A-dopamine (Anaerobic Dopamine)NCT07214285 · lead sponsor · 2025-10-01

Visual (Path)Ways in Multiple Sclerosis - Part IINCT06776224 · lead sponsor · 2025-01-24

Validation of the French Version of the Lithium Knowledge Test (LKT)NCT06033326 · lead sponsor · 2023-11-28

Mepolizumab and Physical Activity in Severe AsthmaNCT05404763 · lead sponsor · 2023-02-02

ACTIVE_NOT_RECRUITING

Lung Ultrasound in the Early Detection of Postoperative Pulmonary Complications After EsophagectomyNCT05453760 · lead sponsor · 2022-08-22

Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control StudyNCT05269069 · lead sponsor · 2022-08-17

Lille Study for Childhood Health PromotionNCT05121090 · lead sponsor · 2022-01-19

ACTIVE_NOT_RECRUITING

Myotonic Dystrophy - Vascular and CognitionNCT04656210 · lead sponsor · 2021-10-14

ACTIVE_NOT_RECRUITING

Consequences of COVID 19 Pandemic on Childhood AsthmaNCT04821908 · lead sponsor · 2021-09-14

Influence of Preprandial Metformin Administration on Carbohydrate AbsorptionNCT04018105 · lead sponsor · 2021-07-28

Sleeve Gastrectomy With Transit Bipartition(SG+TB) Versus Roux-en-Y Gastric Bypass (RYGB) for Type 3 ObesityNCT04915014 · lead sponsor · 2021-07-23

ACTIVE_NOT_RECRUITING

Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital.NCT04852926 · lead sponsor · 2021-07-13

Education for Adapted Physical Activity in Parkinson's DiseaseNCT04340492 · lead sponsor · 2021-03-15

Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"NCT04616664 · lead sponsor · 2021-02-16

Presenteeism in Severe Asthma Treated by BiotherapyasthmaNCT04463589 · lead sponsor · 2021-01-01

Markers of Disease Progression and Gait Within the Parkinsonian PopulationNCT04653688 · lead sponsor · 2020-12-22

Physical Activity Assessment of Patients With Diabetic Foot WoundsNCT04582357 · lead sponsor · 2020-12-01

Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung CancerNCT04589013 · lead sponsor · 2020-11-19

Dopaminergic restauratIon by intraVEntriculaire AdministrationNCT04332276 · lead sponsor · 2020-09-18

Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With ImmunosuppressantsNCT04426279 · lead sponsor · 2020-08-18

Efficacy of Ericksonian Hypnosis in the Management of Chronic Pain Related to Parkinson's DiseaseNCT04259203 · lead sponsor · 2020-08-08

Characteristics of Marrow Fatty Cells in the Ageing of Bone and Joints, Osteoarthritis and OsteoporosisNCT03678831 · lead sponsor · 2020-06-30

Mold Exposure and Impact on Asthma Control in French Asthmatic ChildrenNCT04918394 · lead sponsor · 2020-06-10

Multidimensional Assessment of Dyspnea in AsthmaNCT04286906 · lead sponsor · 2020-05-18

Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 OutbreakNCT04351399 · lead sponsor · 2020-04-27

Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney Transplant Recipient.NCT05662267 · lead sponsor · 2020-03-10

Eosinophils Endotypes in Chronic Airway Inflammatory DiseasesNCT04187976 · lead sponsor · 2020-03-03

Drugs studied in this sponsor's trials

12 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University Hospital, Lille as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo12

deferiprone3

memantine2

caffeine1

letrozole1

methylphenidate1

nilvadipine1

nivolumab Injection1

placebo RxCUI 8375 · Lead sponsor in 9 linked trial(s) · 1 currently recruiting 12 trials deferiprone RxCUI 11645 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials memantine RxCUI 6719 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials caffeine RxCUI 1886 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial letrozole RxCUI 72965 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial methylphenidate RxCUI 6901 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial nilvadipine RxCUI 53692 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial nivolumab Injection RxCUI 1657189 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial ofatumumab RxCUI 712566 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial rivastigmine RxCUI 183379 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial tofacitinib RxCUI 1357536 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial vildagliptin RxCUI 596554 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor138

collaborator29

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.